Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer
Sign Up to like & getrecommendations! Published in 2017 at "ESMO Open"
DOI: 10.1136/esmoopen-2016-000102
Abstract: Introduction No predictive clinical or genetic markers have been identified or validated for antiangiogenic agents in lung cancer. We aimed to identify a predictive clinical marker of benefit for nintedanib, an angiokinase inhibitor, using data… read more here.
Keywords: marker; clinical marker; predictive clinical; lung cancer ... See more keywords
Abstract 634: SOX11 is a potential clinical marker for hormone receptor negative ductal carcinoma in situ
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-634
Abstract: Background: Ductal carcinoma in situ (DCIS) comprises 20-25% of screen-detected breast cancer and, like invasive ductal carcinoma (IDC), is heterogeneous in terms of underlying biology, presentation and outcome. There are limited potential biomarkers of outcome… read more here.
Keywords: carcinoma situ; dcis; ductal carcinoma; clinical marker ... See more keywords
“Arcus retinalis”: A novel clinical marker of sub-internal limiting membrane hemorrhage
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Ophthalmology"
DOI: 10.1177/1120672120934958
Abstract: Introduction: Preretinal hemorrhages can be located in subhyaloid or sub-internal limiting membrane (ILM) space. Though optical coherence tomography (OCT) may help to distinguish the exact location of hemorrhage in selected cases, it is often difficult… read more here.
Keywords: arcus retinalis; ilm hemorrhage; marker sub; hemorrhage ... See more keywords